Partek
Partek provides Partek Flow, a visual bioinformatics software platform for NGS and multiomic data analysis, serving research scientists and core labs through Illumina's global sales channels on a subscription basis.
- Company typePrivate
- Founded1993
- HeadquartersSt Louis, United States
- Headcount51–100
- GTM typeB2B
- OfferingSoftware
What Partek does
Partek is a bioinformatics software company that provides visual analysis tools for next-generation sequencing (NGS) and multiomic data, serving research scientists who lack advanced bioinformatics training. Founded in 1993 and headquartered in St. Louis, Missouri, the company operates with 51–100 employees and functions as a subsidiary/product line of Illumina, Inc. Its core product, Partek Flow, is a visual analysis platform featuring a context-sensitive workflow builder, industry-standard statistical algorithms, and publication-ready interactive visualizations covering bulk RNA-Seq, single-cell, spatial transcriptomics, ChIP-Seq/ATAC-Seq, DNA-Seq, metagenomics, microarray, pathway, and proteomics data types.
Partek firmographics
Firmographics- Name
- Partek
- Legal name
- Partek
- Website
- https://partek.com
- Company type
- Private
- Founded year
- 1993
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Partek provides Partek Flow, a visual bioinformatics software platform for NGS and multiomic data analysis, serving research scientists and core labs through Illumina's global sales channels on a subscription basis.
- Ownership category
- akta.pro rank
Partek industry classification
Industry- Product category
- Bioinformatics Software
- NAICS
- Computer Systems Design and Related Services (54151)
- akta.pro primary industry
- Bioinformatics, Multi-Omics Data Analysis & Interpretation Services (HLAGANAI)
Keywords
Where Partek is headquartered
LocationHeadquarters
- HQ city
- St Louis
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Partek business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure
Revenue model
- Software Licenses: Annual and multi-year licenses for Partek Flow software available in Lab Edition and Enterprise editions with both Illumina-hosted cloud and customer-hosted deployment options. Single-cell/spatial analysis and pathway analysis available as add-ons.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Lab Edition - For small labs and departments with one named user license |
| Subscription | Annual | Enterprise Edition - For large labs, departments, or organizations with many users |
| Subscription | Annual | Add-on: Single Cell and Spatial Analysis |
| Subscription | Annual | Add-on: Pathway Analysis |
| Subscription | Annual | Add-on: 1TB Additional Data Storage |
Go-to-market motion1 record
Distribution channels2 records
Marketing channels4 records
Partek product offering
Product offeringCore offering
Partek develops and sells Partek Flow, a visual bioinformatics software platform for the analysis and visualization of next-generation sequencing (NGS) and large-scale multiomic data. The platform enables researchers of all skill levels to build, save, and share analysis workflows across bulk RNA-Seq, single-cell, spatial transcriptomics, ChIP-Seq/ATAC-Seq, DNA-Seq, metagenomics, microarray, pathway, and proteomics data, delivered as annual and multi-year subscription licenses in Lab and Enterprise editions.
Product overview
Partek is a bioinformatics software product line sold by Illumina, centered on Partek Flow software as the core platform. The portfolio consists of Partek Flow software for multiomic data analysis and visualization, offered in two subscription tiers (Lab Edition and Enterprise Edition), each available in Illumina Hosted and Customer Hosted deployment options. Additional add-on modules extend the platform for Pathway Analysis and Single Cell and Spatial analysis. The platform supports bulk RNA-Seq, single-cell analysis, spatial transcriptomics, ChIP-Seq/ATAC-Seq, DNA-Seq, metagenomics, microarray, pathway, and proteomics applications, enabling researchers of all skill levels to analyze next-generation sequencing and large-scale multiomic data with an intuitive interface and interactive visualizations.
Differentiator
Problem solved
Functional benefit
Products and services
- Partek Flow software User-friendly bioinformatics software for the analysis and visualization of next-generation sequencing and large-scale multiomic data, sold as a subscription to research labs, core facilities, and enterprise organizations. Includes a visual workflow builder, industry-standard statistical algorithms, and interactive publication-ready visualizations across bulk RNA-Seq, single-cell, spatial transcriptomics, ChIP-Seq, ATAC-Seq, DNA-Seq, metagenomics, microarray, pathway, and proteomics data. Offered in Lab Edition and Enterprise Edition tiers and deployed as Illumina-hosted cloud or customer-hosted installations.
Quantifiable outcome
- Publication-ready visualizations reduce time from analysis to submission
Companies that use Partek
Customer profileSegments3 records
Ideal customer profiles3 records
Partek technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
Partek partnerships and signals
Strategic signalScale indicators8 records
Recent moves5 records
Expansion highlights5 records
Partek competitors and assessment
Company assessmentBroad incumbents
- Illumina Connected Multiomics: Illumina's own newer multiomic cloud analysis offering that sits in the same parent portfolio as Partek Flow and competes for the same internal R&D, sales, and customer mindshare.
- QIAGEN Digital Insights: QIAGEN's bioinformatics division offers genomic and clinical interpretation software (e.g., QIAGEN CLC, Ingenuity Pathway Analysis) comparable to Partek Flow's multiomic analysis and pathway analysis capabilities, though at a broader enterprise scale.
Direct peers
- DNAnexus: Cloud-based genomics data analysis and collaboration platform serving pharma, clinical, and research customers, directly competing with Partek Flow's cloud-hosted multiomic analysis and project collaboration features.
- Velsera (formerly Seven Bridges): Provides a genomics and multiomic analysis platform (Velsera Scientific Analysis Platform) with workflow builders and data management features closely aligned to Partek Flow's value proposition.
- Biomatters (Geneious): Geneious Prime offers DNA/RNA-Seq and multiomic analysis with an intuitive visual interface targeting research scientists, directly comparable to Partek Flow's ease-of-use positioning.
- Golden Helix: Specialized genomic data analysis software (SNP & Variation Suite, VarSeq) for variant analysis and NGS workflows, addressing a similar research and clinical customer base as Partek Flow.
Emerging players
- Benchling: Cloud platform for life sciences R&D spanning experiment data, molecular biology, and increasingly bioinformatics workflows, competing for the same enterprise pharma and biotech IT budgets as Partek Flow.
- Genedata: Enterprise bioinformatics platform for biopharma R&D with multiomic data analysis and workflow management, competing with Partek Flow for large pharma and biotech informatics budgets.
- Rosalind (OnRamp Bio): Cloud-based genomics analysis platform with an emphasis on biologist-friendly interpretation of RNA-Seq and other NGS data, overlapping Partek Flow's core research user segment.
Regional players
- Fabric Genomics: Clinical-grade genomic analysis and interpretation software targeting clinical labs and health systems, adjacent to Partek Flow's translational and clinical research use cases.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
Partek social profiles
Digital presencePartek financial estimates
Financial estimateRevenue estimate
Valuation estimate
Partek leadership team
Management profileNumber of profiles
Profiles1 record
Partek funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Partek M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Partek
What does Partek do?
Partek develops and sells Partek Flow, a visual bioinformatics software platform for the analysis and visualization of next-generation sequencing (NGS) and large-scale multiomic data. The platform enables researchers of all skill levels to build, save, and share analysis workflows across bulk RNA-Seq, single-cell, spatial transcriptomics, ChIP-Seq/ATAC-Seq, DNA-Seq, metagenomics, microarray, pathway, and proteomics data, delivered as annual and multi-year subscription licenses in Lab and Enterprise editions.
Is Partek a public or private company?
Partek is a private company. It is classified as corporate owned and is currently operating.
When was Partek founded?
Partek was founded in 1993. It employs 51 to 100 people.
Where is Partek based?
Partek is headquartered in St Louis, United States, in the North America region.
How does Partek make money?
One revenue line is on record: software Licenses.
Who are Partek's main competitors?
Broad incumbents on record are Illumina Connected Multiomics and QIAGEN Digital Insights. Direct peers are DNAnexus, Velsera (formerly Seven Bridges), Biomatters (Geneious) and Golden Helix. Emerging players are Benchling, Genedata and Rosalind (OnRamp Bio). Fabric Genomics is listed as a regional player.
Does Partek have an API?
No public API is recorded for Partek.
What industry is Partek in?
Partek's product category is Bioinformatics Software. Its primary akta.pro industry code is HLAGANAI, Bioinformatics, Multi-Omics Data Analysis & Interpretation Services. Its NAICS code is 54151.